Mindfulness Psychoeducation for Schizophrenia

NCT07310615 | Completed

• 1 other identifier: OMER-RCT-2025-SCH
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to examine the effects of a mindfulness-based psychoeducation program on mindfulness levels and treatment adherence among individuals diagnosed with schizophrenia. Schizophrenia is a chronic psychiatric disorder that affects thinking, emotions, and behavior, and difficulties in adhering to prescribed treatments are commonly observed. Poor treatment adherence is associated with relapse, increased hospitalization, and reduced overall functioning. This randomized controlled study includes 40 patients assigned to either an experimental group or a control group. The experimental group receives a structured mindfulness-based psychoeducation program, while the control group receives treatment as usual without any additional intervention. Assessments are conducted before and after the intervention using a Personal Information Form, a Mindfulness Scale, and the Morisky Medication Adherence Scale.

Conditions

Schizophrenia

Keywords

Schizophrenia; Mindfulness; Psychoeducation; Randomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

• Mindfulness level (Mindful Attention Awareness Scale)

  Mindfulness was assessed using the Mindful Attention Awareness Scale (MAAS). Score range: 15-90. Higher scores indicate greater mindfulness.

  Baseline and 8 weeks after intervention

Secondary Outcomes (2)

• Mindfulness level at 8 weeks (Mindful Attention Awareness Scale)

  8 weeks

• Self-compassion level at 8 weeks (Self-Compassion Scale)

  8 weeks

Study Arms (2)

Mindfulness-Based Psychoeducation

EXPERIMENTAL

Participants will receive an 8-session mindfulness-based psychoeducation program.

Behavioral: Mindfulness-Based Psychoeducation Program

Control: Routine Care

ACTIVE COMPARATOR

Participants in this arm will receive Routine Care provided by the psychiatric outpatient clinic. Routine Care includes standard follow-up, medication management, and usual clinical monitoring. No additional psychoeducation or mindfulness-based intervention will be provided during the study period.

Other: Routine Care

Interventions

Routine Care OTHER

Standard outpatient psychiatric care delivered by the clinic. No additional psychoeducation or mindfulness intervention is provided.

Control: Routine Care

Mindfulness-Based Psychoeducation Program BEHAVIORAL

A structured 8-session mindfulness-based psychoeducation program including mindfulness exercises, psychoeducation, breathing techniques and adherence-support strategies.

Mindfulness-Based Psychoeducation

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of schizophrenia according to DSM-5 criteria
• Age between 18-65 years
• Being clinically stable for at least the past 3 months
• Able to communicate, read, and understand Turkish
• Receiving outpatient psychiatric follow-up
• Willingness to participate and providing informed consent

You may not qualify if:

• Presence of acute psychotic symptoms requiring immediate hospitalization
• Comorbid intellectual disability, neurological disorder, or severe cognitive impairment
• Substance or alcohol dependence within the last 6 months
• Participation in any mindfulness-based or psychoeducational program within the last year
• Severe visual or hearing impairment preventing participation
• Any condition judged by the clinician to contraindicate participation in group sessions

Sponsors & Collaborators

• Ömer USLU: lead

Study Sites (1)

Söke Fehime Faik Kocagöz State Hospital

Aydin, Söke, 09200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Study Officials

• Ömer Uslu, PhD, RN

  Söke Fehime Faik Kocagöz Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Dr. Ömer Uslu, PhD - Principal Investigator

Model Details: Participants were randomly assigned to either the experimental group (mindfulness-based psychoeducation) or the control group with no intervention.

Study Record Dates

• First Submitted: December 9, 2025
• First Posted: December 30, 2025
• Study Start: December 25, 2024
• Primary Completion: July 13, 2025
• Study Completion: September 13, 2025
• Last Updated: December 30, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)